Drug Pipeline & Clinical Insights – October 2026
This month’s Drug Pipeline & Clinical Insights explores three new specialty therapies and what they could mean for pharmacy benefits, including cost, access, and appropriate use.
This author has not written his bio yet.
But we are proud to say that Moyosola contributed 7 entries already.
This month’s Drug Pipeline & Clinical Insights explores three new specialty therapies and what they could mean for pharmacy benefits, including cost, access, and appropriate use.
6 Real-world pharmacy strategies employers use to manage GLP-1s, specialty drugs, and women’s health.
Right now, there’s a storm brewing in specialty drug trend—and most plan sponsors don’t even see it coming. If you’re focused
An expert-led webinar with a pharmacist, a nurse, a doctor, and an HR leader sharing practical steps employers should take to balance cost, access, and outcomes
Offering health benefits to employees is a critical responsibility—and a complex one.
Stay ahead of PBM reform. Discover how new regulations impact employers and plan sponsors—and the steps to take now to manage costs and compliance
Avoid the chaos. Protect your people. Make the switch with confidence.